[ACRX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- -35.18%
YoY- 29.86%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 443 511 738 1,368 2,924 386 475 -4.54%
PBT -9,846 -8,956 -8,918 -8,930 -6,602 -15,925 -14,423 -22.48%
Tax 5 858 698 931 4 843 885 -96.83%
NP -9,851 -8,956 -8,918 -8,930 -6,606 -15,925 -14,423 -22.46%
Tax Rate - - - - - - - -
Total Cost 10,294 9,467 9,656 10,298 9,530 16,311 14,898 -21.86%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -2,223.70 -1,752.64 -1,208.40 -652.78 -225.92 -4,125.65 -3,036.42 -18.76%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -1.65 -1.58 -1.93 -2.03 -1.64 -3.98 -3.63 -40.91%
EPS Diluted -1.65 -1.58 -1.93 -2.03 -1.64 -3.98 -3.63 -40.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.